Cancer Causes & Control

, Volume 7, Issue 5, pp 553–559

Big babies and infant leukemia: a role for insulin-like growth factor-1?

  • Julie A. Ross
  • John P. Perentesis
  • Leslie L. Robison
  • Stella M. Davies

Several epidemiologic studies have demonstrated that high birthweight is associated with an increased risk of infant leukemia; however, the reason for this relationship is unclear. Biologic data demonstrate that birthweight is correlated positively with circulating levels of insulin-like growth factor-1 (IGF-1). IGF-1 is important in blood formation and regulation and has been shown to stimulate the growth of both myeloid and lymphoid cells in culture. Since infants who develop leukemia are likely to have had at least one transforming event occur in utero, we hypothesize that high levels of IGF-1 may both produce a larger baby and contribute to leukemogenesis.

Key words

Birthweight childhood IGF-1 infant leukemia 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    MacMahon B, Newill VA. Birth characteristics of children dying of malignant neoplasms. JNCI 1962; 28: 231–44.Google Scholar
  2. 2.
    Iversen T. Leukaemia in infancy and childhood. A material of 570 Danish cases. Acta Paediatr Scand [Suppl] 1966; 167: 25–50.Google Scholar
  3. 3.
    Jackson EW, Norris FD, Klauber MR. Childhood leukemia in California-born twins. Cancer 1968; 23: 913–9.Google Scholar
  4. 4.
    Fasal E, Jackson EW, Klauber MR. Birth characteristics and leukemia in childhood. JNCI 1971; 47: 501–9.Google Scholar
  5. 5.
    Wertelecki W, Mantel N. Increased birthweight in leukemia. Pediatr Res 1973; 7: 132–8.Google Scholar
  6. 6.
    Hirayma T. Descriptive and analytical epidemiology of childhood malignancy in Japan. In: Kobayashi N, ed. Recent Advances in Management of Children With Cancer. Tokyo, Japan: The Children's Cancer Association of Japan, 1980: 27–43.Google Scholar
  7. 7.
    Daling JR, Starzyk P, Olshan AF, Weiss NS. Birthweight and the incidence of childhood cancer. JNCI 1984; 72: 1039–41.Google Scholar
  8. 8.
    Shaw G, Lavey R, Jackson R, Austin D. Association of childhood leukemia with maternal age, birth origin, and paternal occupation. Am J Epidemiol 1984; 119: 788–95.Google Scholar
  9. 9.
    Eisenberg DE, Sorahan T. Birthweight and childhood cancer deaths. JNCI 1987; 78: 1095–100.Google Scholar
  10. 10.
    Shu XO, Gao YT, Brinton LA, et al. A population-based case-control study of childhood leukemia in Shanghai. Cancer 1988; 62: 635–44.Google Scholar
  11. 11.
    Kaye SA, Robison LL, Smithson WA, Gunderson P, King FL, Neglia JP. Maternal reproductive history and birth characteristics in childhood acute lymphoblastic leukemia. Cancer 1991; 68: 1351–5.Google Scholar
  12. 12.
    Savitz DA, Ananth CV. Birth characteristics of childhood cancer cases, controls, and their siblings. Ped Hematol Oncol 1994; 11: 587–99.Google Scholar
  13. 13.
    Cnattingius S, Zack MM, Ekbom A, et al. Prenatal and neonatal risk factors for childhood lymphatic leukemia. JNCI 1995; 87: 908–14.Google Scholar
  14. 14.
    Cnattingius S, Zack MM, Ekbom A, et al. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biom Prev 1995; 4: 441–5.Google Scholar
  15. 15.
    Ross JA, Potter JD, Shu XO, Reaman GH, Lampkin B, Robison LL. Evaluating the relationships among maternal reproductive history, birth weight, and risk of infant leukemia. A report from the Childrens Cancer Group. Ann Epidemiol (in press).Google Scholar
  16. 16.
    Yeazel MW, Ross JA, Buckley JD, Woods WG, Ruccione K, Robison LL. High birthweight and risk of specific childhood cancers: a report from the Children's Cancer Group. (Submitted).Google Scholar
  17. 17.
    Gurney JG, Severson RK, Davis S, Robison LL. Incidence of cancer in children in the United States. Sex-, race-, and 1-year age-specific rates by histologic type. Cancer 1995; 75: 2186–95.Google Scholar
  18. 18.
    Ross JA, Davies SM, Potter JD, Robison LL. The epidemiology of childhood leukemia with a focus on infants. Epidemiologic Rev 1994; 16: 243–72.Google Scholar
  19. 19.
    Leisenring WM, Breslow NE, Evans IE, Beckwith JB, Coppes MJ, Grundy P. Increased birthweights of National Wilms' Tumor Study patients suggest a growth factor excess. Cancer Res 1994; 54: 4680–3.Google Scholar
  20. 20.
    Weksberg R, Shen DR, Fei YL, Song QL, Squire J. Disruption of insulin-like growth factor 2 imprinting in Beckwith-Wiedemann Syndrome. Nat Genet 1993; 5: 143–50.Google Scholar
  21. 21.
    Ogawa O, Eccles MR, Szeto J, et al. Relaxation of insulin-like growth factor II gene imprinting implicated in Wilms' tumour. Nature 1993; 362: 749–51.Google Scholar
  22. 22.
    Olshan AF. Wilms' tumor, overgrowth, and fetal growth factors. A hypothesis. Cancer Genet Cytogen 1986; 21: 303–7.Google Scholar
  23. 23.
    Insulin-like growth factors. In: Pimental E, ed. Handbook of Growth Factors. Vol II. Peptide Growth Factors. Boca Raton, FL (USA): CRC Press, Inc., 1994: 55–95.Google Scholar
  24. 24.
    Baxter RC. Insulin-like growth factor binding proteins in the human circulation: a review. Horm Res 1994; 42: 140–4.Google Scholar
  25. 25.
    Bennett A, Wilson DM, Liu F, Nagashima R, Rosenfeld RG, Hintz RL. Levels of insulin-like growth factors I and II in human cord blood. J Clin Endocinol Metab 1983; 57: 609–12.Google Scholar
  26. 26.
    Gluckman PD, Johnson-Barrett JJ, Butler JH, Edgar BW, Gunn TR. Studies of insulin-like growth factor-I and-II by specific radioligand assays in umbilical cord blood. Clin Endocrin 1983; 19: 405–13.Google Scholar
  27. 27.
    Ashton IK, Zapf J, Einschenk I, MacKenzie IZ. Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinologica 1985; 110: 558–63.Google Scholar
  28. 28.
    Samaan NA, Schultz PN, Johnston DA, Creasy RW, Gonik B. Growth hormone, somatomedin C, and nonsuppressible insulin-like activity levels compared in premature, small, average birth weight, and large infants. Am J Obstet Gynecol 1987; B; 157: 1524–8.Google Scholar
  29. 29.
    Lasarre C, Hardouin S, Daffos F, Forestier F, Frankenne F, Binoux M. Serum insulin-like growth factors and insulin-like growth factor binding proteins in the human fetus. Relationships with growth in normal subjects with intrauterine growth retardation. Ped Res 1991; 29: 219–25.Google Scholar
  30. 30.
    Salardi S, Orsini LF, Cacciari F, Righetti F, Donati S, Mandini M. Growth hormone, insulin-like growth factor I, insulin and C-peptide during human fetal life: in-utero study. Clin Endocrinol 1991; 34: 187–90.Google Scholar
  31. 31.
    Wang HS, Lim J, English J, Irvine L, Chard T. The concentration of insulin-like growth factor-I and insulin-like growth factor-binding protein-1 in human umbilical cord serum at delivery: relation to fetal weight. J Endrocrinol 1991; 129: 459–64.Google Scholar
  32. 32.
    Delmis J, Drazancic A, Ivanisevic M, Suchanek E. Glucose, insulin, HGH, and IGF-1 levels in maternal serum, amniotic fluid and umbilical venous serum: a comparison between late normal pregnancy and pregnancies complicated with diabetes and fetal growth retardation. J Perinat Med 1992; 20: 47–56.Google Scholar
  33. 33.
    Kubota T, Kamada S, Taguchi M, Aso T. Determination of insulin-like growth factor-2 in feto-maternal circulation during human pregnancy. Acta Endocrinologica 1992; 127: 359–65.Google Scholar
  34. 34.
    Fant M, Salafia C, Baxter RC, et al. Circulating levels of IGFs and IGF binding proteins in human cord serum. Relationships to intrauterine growth. Regulatory Peptides 1993; 48: 29–39.Google Scholar
  35. 35.
    Verhaeghe J, Van Bree R, Van Herck EV, Laureys J, Bouillon R, Van Assch FA. C-peptide, insulin-like growth factors I and II, and insulin-like growth factor binding protein-1 in umbilical cord serum: correlations with birth weight. Am J Obstet Gynecol 1993; 169: 89–97.Google Scholar
  36. 36.
    Reece EA, Wiznitzer A, Le E, Homko CJ, Behram H, Spencer EM. The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol 1994; 84: 88–95.Google Scholar
  37. 37.
    Simmons D. Interrelation between umbilical cord serum sex hormones, sex hormone-binding globulin, insulin-like growth factor 1, and insulin in neonates from normal pregnancies and pregnancies complicated by diabetes. J Clin Endocrinol Metab 1995; 80: 2217–21.Google Scholar
  38. 38.
    Baker J, Liu JP, Robertson EJ, Efstratiadis A. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 1993; 75: 73–82.Google Scholar
  39. 39.
    Perentesis JP, Kersey JH. Biologic therapy in leukemia. In: Henderson ES, Lister TA, Greaves MF, eds. Leukemia, 6th Ed. London, UK: WB Saunders, 1996.Google Scholar
  40. 40.
    Baier TG, Jenne EW, Blum W, Shonberg D, Hartmann KK. Influence of antibodies against IGF-1, insulin or their receptors on proliferation of human acute lymphoblastic leukemia cell lines. Leuk Res 1993; 16: 807–14.Google Scholar
  41. 41.
    Sanders M, Sorba S, Daniak N. Insulin-like growth factors stimulate erythropoiesis in serum-substituted umbilical cord blood cultures. Exper Hematol 1993; 21: 25–30.Google Scholar
  42. 42.
    Jardieu P, Clark R, Mortensen D, Dorshkind K. In vivo administration of insulin-like growth factor-1 stimulates primary B lymphopoiesis and enhances lymphocyte recovery after bone marrow transplantation. J Immunol 1994; 152: 4320–7.Google Scholar
  43. 43.
    Estrov Z, Meir R, Barak Y, Zaizov R, Zadik Z. Human growth hormone and IGF-1 enhances the proliferation of leukemic blasts. J Clin Oncol 1991; 9: 394–9.Google Scholar
  44. 44.
    Shimon I, Shpilberg O. The insulin-like growth factor system in regulation of normal and malignant hematopoiesis. Leuk Res 1995; 19: 233–40.Google Scholar
  45. 45.
    Knudson AG, Meadows AT, Nichols WW, Hill R. Chromosomal deletion and retinoblastoma. N Engl J Med 1976; 295: 1120–3.Google Scholar
  46. 46.
    Volgelstein V, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal-tumor development. N Engl J Med 1988; 319: 525–32.Google Scholar
  47. 47.
    Limpens J, Stad R, Vos C, et al. Lymphoma-associated translocation t(14;18) in blood B cells of normal individuals. Blood 1995; 85: 2528–36.Google Scholar
  48. 48.
    Nucifora G, Larson RH, Rowley JD. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long term remission. Blood 1993; 82: 712–5.Google Scholar
  49. 49.
    Morris JA. A mutational theory of leukemogenesis. J Clin Pathol 1989; 42: 337–40.Google Scholar
  50. 50.
    Wasserman R, Galili N, Ito Y, Reichard BA, Shane S, Rovera G. Predominance of fetal type DJH joining in young children with B-precursor lymphoblastic leukemia as evidence for an in utero transforming event. J Exper Med 1992; 176: 1577–81.Google Scholar
  51. 51.
    Steenbergen EJ, Verhagen OJ, Van Leeuwen EF, et al. B-precursor acute lymphoblastic leukemia third complementarily determining regions predominantly represent an unbiased recombination repertoire: leukemic transformation frequently occurs in fetal life. Euro J Immunol 1994; 24: 900–8.Google Scholar
  52. 52.
    Ford AM, Ridge SA, Cabrera ME, et al. In utero rearrangements in the trithorax-related oncogene in infant leukemias. Nature 1993; 363: 358–60.Google Scholar
  53. 53.
    Mahmoud HH, Ridge SA, Behm FG, et al. Intrauterine monoclonal origin of neonatal concordant acute lymphoblastic leukemia in monozygotic twins. Med Ped Oncol 1995; 24: 77–81.Google Scholar
  54. 54.
    Greaves MJ, Chan LC. Is spontaneous mutation the major ‘cause’ of childhood acute lymphoblastic leukemia? Br J Hematol 1986; 64: 1–13.Google Scholar
  55. 55.
    Metcalf D, Rasko JEJ. Leukemic transformation of immortalized FDC-P1 engrafted in GM-CSF transgenic mice. Blood 1993; 7: 878–86.Google Scholar
  56. 56.
    Cannistra SA, Groshak P, Griffin JD. Granulocyte-macrophage colony-stimulating factor enhances the cytotoxic effects of cytosine arabinoside in acute myeloblastic leukemia and in the myeloid blast crisis phase of chronic myelogenous leukemia. Leukemia 1989; 3: 328–34.Google Scholar
  57. 57.
    Buchner T, Hiddemann W, Koenigsmann M, et al. Recombinant human granulocyte-macrophage colony stimulating factor after chemotherapy in patients with acute myeloid leukemia at higher age after relapse. Blood 1991; 78: 1190–7.Google Scholar
  58. 58.
    Ganser A, Volkers B, Greher J, et al. Recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes — a phase I/II trial. Blood 1989; 73: 31–7.Google Scholar
  59. 59.
    Herrmann F, Lindemann A, Klein H, Lubbert M, Shulz G, Mertelsmann R. Effect of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome with excess blasts. Leukemia 1989; 31: 335–8.Google Scholar
  60. 60.
    Williams GT, Smith CA. Molecular regulation of apoptosis. genetic controls on cell death. Cell 1993; 74: 777–9.Google Scholar
  61. 61.
    Fisher DE. Apoptosis in cancer therapy: crossing the threshold. Cell 1994; 78: 539–42.Google Scholar
  62. 62.
    Pui CH, Frankel LS, Carroll AJ, et al. Clinical characteristics and treatment outcome of childhood acute lymphoblastic leukemia with the t(4;11)(q21;q23). A collaborative study of 40 cases. Blood 1991; 77: 440–7.Google Scholar
  63. 63.
    Neiman PE, Thomas SJ, Loring G. Induction of apoptosis during normal and neoplastic B-cell development in the bursa of Fabricus. Proc Natl Acad Sci USA 1991; 88: 5857–61.Google Scholar
  64. 64.
    Muta K, Krantz SB. Apoptosis of human erythroid colony-forming cells is decreased by stem cell factor and insulin-like growth factor I as well as erythropoietin. J Cell Physiol 1993; 156: 264–71.Google Scholar
  65. 65.
    Reaman G, Zeltzer P, Bleyer WA, et al. Acute lymphoblastic leukemia in infants less than one year of age. A cumulative experience of the Childrens Cancer Study Group. Blood 1985; 3: 1513–21.Google Scholar
  66. 66.
    Department of Health and Human Services. Compilations of Data on Natality, Mortality, Marriage, Divorce, and Induced Terminations of Pregnancy. No 1. Hyattsville, MD (USA): DHHS, May 1989; DHHS Publication No. (PHS) 89-1951, Vital and Health Statistics Supplements to the Monthly Vital Statistics Report. Series 24.Google Scholar

Copyright information

© Rapid Science Publishers 1996

Authors and Affiliations

  • Julie A. Ross
  • John P. Perentesis
  • Leslie L. Robison
  • Stella M. Davies

There are no affiliations available

Personalised recommendations